BROOKDALE SENIOR LIVING INC (BKD) Fundamental Analysis & Valuation
NYSE:BKD • US1124631045
Current stock price
13.95 USD
+0.06 (+0.43%)
At close:
14.29 USD
+0.34 (+2.44%)
Pre-Market:
This BKD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. BKD Profitability Analysis
1.1 Basic Checks
- In the past year BKD has reported negative net income.
- BKD had a positive operating cash flow in the past year.
- BKD had negative earnings in each of the past 5 years.
- BKD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -4.41%, BKD is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
- BKD has a worse Return On Invested Capital (1.27%) than 61.00% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for BKD is significantly below the industry average of 8.86%.
- The 3 year average ROIC (0.80%) for BKD is below the current ROIC(1.27%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.41% | ||
| ROE | N/A | ||
| ROIC | 1.27% |
ROA(3y)-3.66%
ROA(5y)-3.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)0.8%
ROIC(5y)N/A
1.3 Margins
- BKD has a Operating Margin (2.71%) which is comparable to the rest of the industry.
- BKD's Operating Margin has improved in the last couple of years.
- BKD has a Gross Margin of 26.22%. This is comparable to the rest of the industry: BKD outperforms 55.00% of its industry peers.
- In the last couple of years the Gross Margin of BKD has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.71% | ||
| PM (TTM) | N/A | ||
| GM | 26.22% |
OM growth 3YN/A
OM growth 5Y67.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.62%
GM growth 5Y3.09%
2. BKD Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BKD is destroying value.
- BKD has more shares outstanding than it did 1 year ago.
- BKD has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for BKD is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -0.10, we must say that BKD is in the distress zone and has some risk of bankruptcy.
- BKD's Altman-Z score of -0.10 is on the low side compared to the rest of the industry. BKD is outperformed by 78.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.1 |
ROIC/WACC0.16
WACC8.03%
2.3 Liquidity
- BKD has a Current Ratio of 0.98. This is a bad value and indicates that BKD is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.98, BKD is not doing good in the industry: 74.00% of the companies in the same industry are doing better.
- A Quick Ratio of 0.98 indicates that BKD may have some problems paying its short term obligations.
- BKD has a worse Quick ratio (0.98) than 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.98 |
3. BKD Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 6.74% over the past year.
- The Revenue has been growing slightly by 2.19% in the past year.
- BKD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.04% yearly.
EPS 1Y (TTM)6.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.05%
Revenue 1Y (TTM)2.19%
Revenue growth 3Y4.17%
Revenue growth 5Y-2.04%
Sales Q2Q%-3.44%
3.2 Future
- BKD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.54% yearly.
- The Revenue is expected to grow by 2.48% on average over the next years.
EPS Next Y72.01%
EPS Next 2Y43.66%
EPS Next 3Y32.54%
EPS Next 5YN/A
Revenue Next Year-5.37%
Revenue Next 2Y-0.9%
Revenue Next 3Y2.48%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. BKD Valuation Analysis
4.1 Price/Earnings Ratio
- BKD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BKD. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BKD is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 16.1 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as BKD's earnings are expected to grow with 32.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.66%
EPS Next 3Y32.54%
5. BKD Dividend Analysis
5.1 Amount
- BKD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BKD Fundamentals: All Metrics, Ratios and Statistics
13.95
+0.06 (+0.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-18 2026-02-18/amc
Earnings (Next)05-04 2026-05-04
Inst Owners103.57%
Inst Owner Change3.02%
Ins Owners0.98%
Ins Owner Change4.33%
Market Cap3.32B
Revenue(TTM)3.19B
Net Income(TTM)-262.69M
Analysts80
Price Target18.46 (32.33%)
Short Float %15.62%
Short Ratio6.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.25%
Min EPS beat(2)-16.31%
Max EPS beat(2)-0.19%
EPS beat(4)0
Avg EPS beat(4)-48.1%
Min EPS beat(4)-145.33%
Max EPS beat(4)-0.19%
EPS beat(8)1
Avg EPS beat(8)-34.78%
EPS beat(12)3
Avg EPS beat(12)-19.96%
EPS beat(16)4
Avg EPS beat(16)-14.26%
Revenue beat(2)0
Avg Revenue beat(2)-2.63%
Min Revenue beat(2)-2.69%
Max Revenue beat(2)-2.57%
Revenue beat(4)0
Avg Revenue beat(4)-2.04%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)-1.36%
Revenue beat(8)0
Avg Revenue beat(8)-1.57%
Revenue beat(12)0
Avg Revenue beat(12)-1.27%
Revenue beat(16)0
Avg Revenue beat(16)-1.05%
PT rev (1m)8.38%
PT rev (3m)65.3%
EPS NQ rev (1m)70.65%
EPS NQ rev (3m)71.88%
EPS NY rev (1m)37.33%
EPS NY rev (3m)50.8%
Revenue NQ rev (1m)2.97%
Revenue NQ rev (3m)2.87%
Revenue NY rev (1m)-0.75%
Revenue NY rev (3m)-0.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.04 | ||
| P/FCF | N/A | ||
| P/OCF | 15.21 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.1 |
EPS(TTM)-0.83
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-1.24
FCFYN/A
OCF(TTM)0.92
OCFY6.57%
SpS13.43
BVpS-0.19
TBVpS-0.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.41% | ||
| ROE | N/A | ||
| ROCE | 1.61% | ||
| ROIC | 1.27% | ||
| ROICexc | 1.34% | ||
| ROICexgc | 1.35% | ||
| OM | 2.71% | ||
| PM (TTM) | N/A | ||
| GM | 26.22% | ||
| FCFM | N/A |
ROA(3y)-3.66%
ROA(5y)-3.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)0.8%
ROIC(5y)N/A
ROICexc(3y)0.84%
ROICexc(5y)N/A
ROICexgc(3y)0.85%
ROICexgc(5y)N/A
ROCE(3y)1.01%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y66.67%
ROICexc growth 3YN/A
ROICexc growth 5Y67.41%
OM growth 3YN/A
OM growth 5Y67.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.62%
GM growth 5Y3.09%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.28 | ||
| Cap/Depr | 138.42% | ||
| Cap/Sales | 16.05% | ||
| Interest Coverage | 0.36 | ||
| Cash Conversion | 47.72% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | -0.1 |
F-Score5
WACC8.03%
ROIC/WACC0.16
Cap/Depr(3y)96.46%
Cap/Depr(5y)79.58%
Cap/Sales(3y)11.24%
Cap/Sales(5y)9.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.05%
EPS Next Y72.01%
EPS Next 2Y43.66%
EPS Next 3Y32.54%
EPS Next 5YN/A
Revenue 1Y (TTM)2.19%
Revenue growth 3Y4.17%
Revenue growth 5Y-2.04%
Sales Q2Q%-3.44%
Revenue Next Year-5.37%
Revenue Next 2Y-0.9%
Revenue Next 3Y2.48%
Revenue Next 5YN/A
EBIT growth 1Y57.24%
EBIT growth 3YN/A
EBIT growth 5Y64.01%
EBIT Next Year794.75%
EBIT Next 3Y127.12%
EBIT Next 5YN/A
FCF growth 1Y-105.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.2%
OCF growth 3Y304.27%
OCF growth 5Y1.18%
BROOKDALE SENIOR LIVING INC / BKD Fundamental Analysis FAQ
What is the fundamental rating for BKD stock?
ChartMill assigns a fundamental rating of 2 / 10 to BKD.
Can you provide the valuation status for BROOKDALE SENIOR LIVING INC?
ChartMill assigns a valuation rating of 1 / 10 to BROOKDALE SENIOR LIVING INC (BKD). This can be considered as Overvalued.
How profitable is BROOKDALE SENIOR LIVING INC (BKD) stock?
BROOKDALE SENIOR LIVING INC (BKD) has a profitability rating of 3 / 10.
How financially healthy is BROOKDALE SENIOR LIVING INC?
The financial health rating of BROOKDALE SENIOR LIVING INC (BKD) is 0 / 10.